NMRA

NASD Neumora Therapeutics, Inc.
Oct 5, 2026 · 4:42 PM ET LAST TRADE Market Closed

$0.5040 ↓ -0.0213 (-4.05%) Trading Down from the previous close of $0.5253, $0.0296 below the day’s high of $0.5336

YTD change
-71.84%
vs 20-day SMA
-39.36%
vs 200-day SMA
-73.84%

Price ranges

Previous day
$0.4801 $0.5595
open $0.5595 close $0.4999
-$0.0596 (-10.65%)
Today
$0.4717 $0.5336
open $0.5000 now $0.5040
+$0.0040 (+0.80%)
Past week
$0.4801 $0.7469
from $0.6776 now $0.5040
-$0.1736 (-25.62%)
Past month
$0.4801 $1.3600
from $1.3500 now $0.5040
-$0.8460 (-62.67%)
This year
$0.4717 $3.6500
from $1.7900 now $0.5040
-$1.2860 (-71.84%)

Price & Performance

-1.62 (-76.42%) / 6M

$0.3423$1.10$1.87$2.63Apr 6Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 97.6% away from all-time highs of $21.0000
  • NMRA is down 72% since the beginning of the year
  • NMRA is down 72% over the past 12 months
  • NMRA is down 63% over the past 1 month
  • 5% of all NMRA investors are betting against NMRA

NMRA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -73.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.23
Earnings momentum -16.3% Quarterly EPS growth
Quarterly change -16.3%

Valuation

P/E ratio N/A
Enterprise value $29.0M
Beta 2.97

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$116.8M
Debt$53.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $94.7M

Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. The firm offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. It focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,142.85 -0.61%
JNJ Johnson & Johnson $256.03 -1.02%
ABBV AbbVie, Inc. $262.82 +1.11%
MRK Merck & Co., Inc. $144.30 +0.34%
RHHVF Roche Holding Ltd $428.22 -3.25%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.